{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:4594",
      "entity_text" : "omeprazole",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:9875401",
      "entity_text" : "rivaroxaban",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0800" ],
      "CellLine" : [ "cellosaurus:CVCL_AV82" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0000813" ]
    }
  },
  "verbose_text" : "There are no known clinically significant drug-drug interactions between rivaroxaban and omeprazole and between rivaroxaban and digoxin.19 Although not performed in our patient, patch testing and lymphocyte transformation test (LTT) are two tools which may help confirm the presence of rivaroxaban allergy.",
  "reading_complete" : "2020-08-03T11:16:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:15:46Z",
  "trigger" : "interactions",
  "evidence" : [ "interactions between rivaroxaban and omeprazole" ],
  "pmc_id" : "7141729",
  "score" : 0
}